Faced With Criticism, Bayh Dole-like Act At Bay In India; Government Takes Up Closer Scrutiny (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Patenting of public-funded research for innovation - an idea mooted a few years ago by India's former science and technology minister Kapil Sibal reflecting mostly from the Bayh-Dole Act in the U.S. - is now pending scrutiny by the Parliamentary Standing Committee before enactment but in its two-year-long run up has unobtrusively created a deep divide among the rank and file of the Indian pharmaceutical industry